Below are the most recent publications written about "Telemedicine" by people in Profiles.
-
Jain T, Schwarz EB, Mehrotra A. A Study of Telecontraception. N Engl J Med. 2019 09 26; 381(13):1287-1288.
-
Sprecher E, Finkelstein JA. Telemedicine and Antibiotic Use: One Click Forward or Two Steps Back? Pediatrics. 2019 09; 144(3).
-
Ray KN, Uscher-Pines L, Mehrotra A. Authors' Response. Pediatrics. 2019 08; 144(2).
-
Paganoni S, van de Rijn M, Drake K, Burke K, Doyle M, Ellrodt AS, Nicholson K, Atassi N, de Marchi F, Babu S, Estrada J, Schwamm LH, Berry JD. Adjusted cost analysis of video televisits for the care of people with amyotrophic lateral sclerosis. Muscle Nerve. 2019 08; 60(2):147-154.
-
Finkelstein JB, Cahill D, Kurtz MP, Campbell J, Schumann C, Varda BK, Grant R, Humphrey K, Meyers H, Nelson CP, Estrada CR. The Use of Telemedicine for the Postoperative Urological Care of Children: Results of a Pilot Program. J Urol. 2019 07; 202(1):159-163.
-
Lee MS, Nambudiri V. Integrating Telemedicine Into Training: Adding Value to Graduate Medical Education Through Electronic Consultations. J Grad Med Educ. 2019 06; 11(3):251-254.
-
Wills AM, Garry J, Hubbard J, Mezoian T, Breen CT, Ortiz-Miller C, Nalipinski P, Sullivan S, Berry JD, Cudkowicz M, Paganoni S, Chan J, Macklin EA. Nutritional counseling with or without mobile health technology: a randomized open-label standard-of-care-controlled trial in ALS. BMC Neurol. 2019 May 29; 19(1):104.
-
Haldane V, Koh JJK, Srivastava A, Teo KWQ, Tan YG, Cheng RX, Yap YC, Ong PS, Van Dam RM, Foo JM, Müller-Riemenschneider F, Koh GC, Foong PS, Perel P, Legido-Quigley H. User Preferences and Persona Design for an mHealth Intervention to Support Adherence to Cardiovascular Disease Medication in Singapore: A Multi-Method Study. JMIR Mhealth Uhealth. 2019 05 28; 7(5):e10465.
-
Raber I, McCarthy CP, Yeh RW. Health Insurance and Mobile Health Devices: Opportunities and Concerns. JAMA. 2019 May 14; 321(18):1767-1768.
-
Funes CJ, Mace RA, Macklin EA, Plotkin SR, Jordan JT, Vranceanu AM. First report of quality of life in adults with neurofibromatosis 2 who are deafened or have significant hearing loss: results of a live-video randomized control trial. J Neurooncol. 2019 Jul; 143(3):505-513.